Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fateme Zare

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Clinical and Experimental Medicine|January 17, 2026
Long non-coding RNAs and therapeutic resistance in multiple myeloma: from molecular insights to clinical applicationsMohamad Hosein Safari, Najma Farahani, Amirhossein Faghih Ojaroodi, et al.
RSC Advances|November 6, 2024
Design, synthesis, biological evaluation, and <i>in silico</i> studies of novel <i>N</i>-substituted-2-(3,4,5-trimethoxyphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazole-6-carboxamides as promising anticancer agentsNavid Dastyafteh, Manica Negahdaripour, Mohammad Hosein Sayahi, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Clinical and Experimental Medicine|January 17, 2026
Long non-coding RNAs and therapeutic resistance in multiple myeloma: from molecular insights to clinical applicationsMohamad Hosein Safari, Najma Farahani, Amirhossein Faghih Ojaroodi, et al.
RSC Advances|November 6, 2024
Design, synthesis, biological evaluation, and <i>in silico</i> studies of novel <i>N</i>-substituted-2-(3,4,5-trimethoxyphenyl)-1<i>H</i>-benzo[<i>d</i>]imidazole-6-carboxamides as promising anticancer agentsNavid Dastyafteh, Manica Negahdaripour, Mohammad Hosein Sayahi, et al.
Pageof 8